Meghan Murray
Program & Portfolio Management Director, Interventional Oncology
Professional Overview
Meghan Murray is an accomplished engineering and program management professional with extensive experience in the medical device and pharmaceutical industries. As the Director of Program & Portfolio Management for the Engineering Sciences division of Interventional Oncology at Johnson & Johnson, she plays a pivotal role in driving the development and commercialization of innovative cancer treatment solutions.
Experience Summary
Current Role
In her current position, Meghan is responsible for leading cross-functional teams to strategically manage the portfolio of engineering and product development initiatives within the Interventional Oncology business. She oversees project planning, resource allocation, and risk mitigation to ensure the timely and successful delivery of life-saving medical technologies. Meghan's strong technical expertise, combined with her exceptional project management skills, has enabled her to drive measurable improvements in operational efficiency and accelerate the advancement of critical oncology interventions.
Career Progression
Meghan's career journey has been marked by a steady progression of leadership roles and increasing responsibilities. Prior to her current position, she served as the Senior Manager for the Engineering Sciences Lung Cancer Initiative at Johnson & Johnson, where she spearheaded the development of novel therapeutic solutions for lung cancer patients. Earlier in her career, Meghan held positions as a Research and Development Manager and Staff Engineer/Project Leader at Mitek Sports Medicine, where she played a crucial role in the design and implementation of sports medicine products.
Academic Background
Meghan holds a Bachelor of Science degree in Biomedical Engineering from Worcester Polytechnic Institute, where she honed her technical skills and developed a deep understanding of the medical device industry.
Areas of Expertise
- Biomedical engineering design and development
- Program and portfolio management
- Cross-functional team leadership
- Regulatory compliance and quality assurance
- Innovative oncology treatment solutions
- Medical device product commercialization
Professional Impact
Meghan's contributions have had a significant impact on the advancement of medical technologies and the quality of care for cancer patients. She has led the successful development and launch of several cutting-edge interventional oncology devices, which have improved patient outcomes and enhanced the standard of care. Meghan's dedication to driving innovation and her ability to effectively navigate complex regulatory environments have positioned her as a respected leader in the industry.
Conclusion
With her proven track record of success, strong technical expertise, and strategic program management capabilities, Meghan Murray is poised to continue making a meaningful impact in the field of interventional oncology. Her commitment to developing life-changing medical solutions and her ability to lead high-performing teams make her a valuable asset to Johnson & Johnson and the broader healthcare community.
